IPO registrations (S-1, F-1) · Registrants
ACHIEVE LIFE SCIENCES, INC.
- SEC CIK
- 949858 · filings on EDGAR ↗
- Former names
- ONCOGENEX PHARMACEUTICALS, INC. (2008–2017); SONUS PHARMACEUTICALS INC (1996–2008)
- Registration
- Form S-1, first filed 2018-05-10, last 2020-11-30; 6 initial registrations, 7 amendments
- Outcome
- Final prospectus filed 2018-06-15; declared effective 2018-06-14
- Industry (SIC)
- In Vitro & In Vivo Diagnostic Substances 2835
- Incorporated in
- DE
- Business address
- 22722 29TH DR. SE, SUITE 100, Seattle, WA 98021
- EIN
- 95-4343413
- Ticker
- ACHV (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- ACHIEVE LIFE SCIENCES, INC. on the corporate pages
On this site
- Business registration: ACHIEVE LIFE SCIENCES, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: Achieve Life Sciences, Inc. Fuzzy (name and state)
- Business registration: Achieve Life Sciences, Inc. Fuzzy (name and state)
- Business registration: Achieve Life Sciences, Inc. Fuzzy (name and state)
- Business registration: Achieve Life Sciences, Inc. Fuzzy (name and state)
- Business registration: Achieve Life Sciences, Inc. Fuzzy (name and state)
- Business registration: ACHIEVE LIFE SCIENCES, INC. Fuzzy (name and state)
- Business registration: ACHIEVE LIFE SCIENCES, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: ACHIEVE LIFE SCIENCES INC. EXACT (EIN (EXACT))
- Federal award recipient: ACHIEVE LIFE SCIENCES, INC. Fuzzy (name and state)
- Form D issuer: ACHIEVE LIFE SCIENCES, INC. EXACT (CIK (EXACT))
- SEC filer: ACHIEVE LIFE SCIENCES, INC. EXACT (CIK (EXACT))
Filings 26
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2018-05-10 | S-1 | S-1 (registration) | ACHIEVE LIFE SCIENCES, INC. | 0001564590-18-013048 ↗ |
| 2018-06-06 | S-1/A | S-1/A (amendment) | ACHIEVE LIFE SCIENCES, INC. | 0000950123-18-006151 ↗ |
| 2018-06-12 | S-1/A | S-1/A (amendment) | ACHIEVE LIFE SCIENCES, INC. | 0001564590-18-015483 ↗ |
| 2018-06-13 | S-1/A | S-1/A (amendment) | ACHIEVE LIFE SCIENCES, INC. | 0001564590-18-015552 ↗ |
| 2018-06-14 | S-1MEF | S-1MEF (added securities) | ACHIEVE LIFE SCIENCES, INC. | 0000950123-18-006354 ↗ |
| 2018-06-14 | EFFECT | EFFECT (declared effective) | ACHIEVE LIFE SCIENCES, INC. | 9999999995-18-001501 ↗ |
| 2018-06-15 | 424B4 | 424B4 (final prospectus) | ACHIEVE LIFE SCIENCES, INC. | 0000950123-18-006385 ↗ |
| 2018-11-29 | S-1 | S-1 (registration) | ACHIEVE LIFE SCIENCES, INC. | 0001564590-18-030281 ↗ |
| 2018-12-07 | EFFECT | EFFECT (declared effective) | ACHIEVE LIFE SCIENCES, INC. | 9999999995-18-003070 ↗ |
| 2019-02-11 | EFFECT | EFFECT (declared effective) | ACHIEVE LIFE SCIENCES, INC. | 9999999995-19-000160 ↗ |
| 2019-07-25 | S-1 | S-1 (registration) | ACHIEVE LIFE SCIENCES, INC. | 0001564590-19-026112 ↗ |
| 2019-08-02 | S-1/A | S-1/A (amendment) | ACHIEVE LIFE SCIENCES, INC. | 0001193125-19-212045 ↗ |
| 2019-08-07 | EFFECT | EFFECT (declared effective) | ACHIEVE LIFE SCIENCES, INC. | 9999999995-19-001830 ↗ |
| 2019-11-06 | S-1 | S-1 (registration) | ACHIEVE LIFE SCIENCES, INC. | 0001564590-19-040706 ↗ |
| 2019-12-02 | S-1/A | S-1/A (amendment) | ACHIEVE LIFE SCIENCES, INC. | 0001564590-19-044975 ↗ |
| 2019-12-16 | S-1/A | S-1/A (amendment) | ACHIEVE LIFE SCIENCES, INC. | 0001564590-19-046005 ↗ |
| 2019-12-17 | EFFECT | EFFECT (declared effective) | ACHIEVE LIFE SCIENCES, INC. | 9999999995-19-002839 ↗ |
| 2019-12-18 | 424B4 | 424B4 (final prospectus) | ACHIEVE LIFE SCIENCES, INC. | 0001193125-19-316899 ↗ |
| 2020-06-05 | S-1 | S-1 (registration) | ACHIEVE LIFE SCIENCES, INC. | 0001564590-20-028496 ↗ |
| 2020-06-16 | EFFECT | EFFECT (declared effective) | ACHIEVE LIFE SCIENCES, INC. | 9999999995-20-001449 ↗ |
| 2020-11-13 | S-1 | S-1 (registration) | ACHIEVE LIFE SCIENCES, INC. | 0001564590-20-053884 ↗ |
| 2020-11-30 | S-1/A | S-1/A (amendment) | ACHIEVE LIFE SCIENCES, INC. | 0001564590-20-055567 ↗ |
| 2020-12-02 | S-1MEF | S-1MEF (added securities) | ACHIEVE LIFE SCIENCES, INC. | 0001564590-20-055951 ↗ |
| 2020-12-02 | EFFECT | EFFECT (declared effective) | ACHIEVE LIFE SCIENCES, INC. | 9999999995-20-003366 ↗ |
| 2020-12-04 | 424B4 | 424B4 (final prospectus) | ACHIEVE LIFE SCIENCES, INC. | 0001564590-20-056113 ↗ |
| 2022-01-05 | EFFECT | EFFECT (declared effective) | ACHIEVE LIFE SCIENCES, INC. | 9999999995-22-000049 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Fuhrman Alan | Officer | Senior Vice President & CFO | 3 | 2006–2008 | |
| MARTINO MICHAEL A | Director; Director,Officer; Other | President & CEO | 13 | 2006–2010 | |
| STEWART MICHAEL B | Officer | Sr. VP & Chief Medical Officer | 1 | 2006 | |
| BURRIS MICHELLE | Director; Officer | CFO | 7 | 2006–2012 | |
| DUNBAR GEORGE W JR | Director | 3 | 2006–2007 | ||
| IVY ROBERT E | Director | 3 | 2006–2007 | ||
| WINSTEAD DWIGHT | Director | 5 | 2006–2010 | ||
| Eudy Craig Steven | Officer | Principal Accounting Officer | 2 | 2006–2007 | |
| Anderson Stephen Charles | Officer | CFO and Secretary; CFO & Secretary | 10 | 2008–2010 | |
| Brady Patrick Robert | Director | 4 | 2008–2009 | ||
| Clendeninn Neil James | Director | 17 | 2008–2016 | ||
| Cormack Scott Daniel | Director; Director,Officer; Officer | President and CEO; President & CEO | 41 | 2008–2020 | |
| JACOBS CINDY | Director,Officer; Officer | EVP, CMO; Exec. VP & Chief Med. Officer; President & CMO | 49 | 2008–2025 | |
| VENTURES WEST CAPITAL LTD | TenPercentOwner | 2 | 2008 | ||
| H.I.G. HORIZON CORP | TenPercentOwner | 3 | 2008–2009 | ||
| H.I.G. KEY CORP | TenPercentOwner | 3 | 2008–2009 | ||
| H.I.G. ONCOGENEX, INC. | TenPercentOwner | 3 | 2008–2009 | ||
| MNAYMNEH SAMI | TenPercentOwner | 3 | 2008–2009 | ||
| TAMER ANTHONY | TenPercentOwner | 3 | 2008–2009 | ||
| Lawrence Cameron William | Officer | Principal Accounting Officer; Principal Financial Officer | 5 | 2010–2012 | |
| GOLDSTEIN JACK | Director | 12 | 2010–2016 | ||
| PARKER H STEWART | Director | 16 | 2010–2020 | ||
| MATTINGLY MARTIN A | Director | 16 | 2010–2022 | ||
| Smith David V | Director | 9 | 2010–2016 | ||
| Wyrick Susan D. | Officer | PAO | 6 | 2013–2014 | |
| Bencich John | Director,Officer; Officer | CEO; CFO; CFO and PFO; CFO & COO | 36 | 2014–2024 | |
| Clarke Anthony | Director,Officer; Officer | Chief Scientific Officer; CSO; President & CSO | 11 | 2017–2022 | |
| Joseph Donald | Director | 8 | 2017–2022 | ||
| MOYES JAY M | Director | 8 | 2017–2022 | ||
| Stewart Richard Alistair | Director; Director,Officer | Chairman & CEO; Chief Executive Officer; Chieve Executive Officer; Executive Chairman; President & CEO | 25 | 2017–2026 | |
| Schacter Robert | TenPercentOwner | 1 | 2017 | ||
| ARMISTICE CAPITAL, LLC | TenPercentOwner | 3 | 2019 | ||
| Armistice Capital Master Fund Ltd. | TenPercentOwner | 3 | 2019 | ||
| Boyd Steven | TenPercentOwner | 3 | 2019 | ||
| Wan Jerry | Officer | Principal Accounting Officer | 16 | 2020–2026 | |
| Martell Bridget A | Director | 6 | 2021–2025 | ||
| Innovation Credit Fund VIII-A, L.P. | TenPercentOwner | 13 | 2021–2022 | ||
| SVB FINANCIAL GROUP | TenPercentOwner | 13 | 2021–2022 | ||
| SVB Innovation Credit Fund VIII, L.P. | TenPercentOwner | 13 | 2021–2022 | ||
| SVB Innovation Credit Partners VIII-A, LLC | TenPercentOwner | 13 | 2021–2022 | ||
| SVB Innovation Credit Partners VIII, LLC | TenPercentOwner | 13 | 2021–2022 | ||
| HIMES VAUGHN B | Director | 4 | 2022–2024 | ||
| DIALECTIC CAPITAL MANAGEMENT, LP | TenPercentOwner | 1 | 2022 | ||
| Dialectic Life Sciences SPV LLC | TenPercentOwner | 1 | 2022 | ||
| Dialectic LS Manager LLC | TenPercentOwner | 1 | 2022 | ||
| Dialectic Partners, LLC | TenPercentOwner | 1 | 2022 | ||
| FICHTHORN JOHN | TenPercentOwner | 1 | 2022 | ||
| Duty Stuart | Director | 5 | 2023–2025 | ||
| KING THOMAS BRAXTON | Director; Director,Officer | Executive Chairman | 7 | 2023–2025 | |
| Sellig Thomas | Director | 6 | 2023–2026 | ||
| Xinos Jaime | Officer | Chief Commercial Officer | 6 | 2024–2026 | |
| Oki Mark K | Officer | Chief Financial Officer | 6 | 2024–2026 | |
| Phelan Nancy R. | Director | 4 | 2025–2026 | ||
| Slaoui Kristen B. | Director | 3 | 2025 | ||
| Donnelly Craig | Officer | Chief Operations Officer | 3 | 2025–2026 | |
| Atkisson Erik | Officer | Chief Legal Officer | 2 | 2025 | |
| Rubinstein Mark Lawrence | Officer | Chief Medical Officer | 2 | 2026 | |
| Goldberg Andrew D. | Director,Officer | CEO and President | 2 | 2026 | |
| COULTER JAMES G | TenPercentOwner | 1 | 2026 | ||
| Iancovici Lucian | Director | 1 | 2026 | ||
| TPG GP A, LLC | TenPercentOwner | 1 | 2026 | ||
| WINKELRIED JON | TenPercentOwner | 1 | 2026 | ||
| Royston Aaron | Director | 2 | 2026 | ||
| Martin Christopher Nathan | Director | 3 | 2026 | ||
| Farrow Jeffrey S | Director | 3 | 2026 | ||
| Waldman Reid Alexander | Director | 3 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2022-11-29 | ACHIEVE LIFE SCIENCES, INC. | Biotechnology | $25,000,000 | $18,900,000 | 16 | 2 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.